Literature DB >> 24191872

Laser photocoagulation enhances adeno-associated viral vector transduction of mouse retina.

Si Hyung Lee1, Peter Colosi, Heuiran Lee, Young-Hoon Ohn, Sung-Woon Kim, Hyung Woo Kwak, Tae Kwann Park.   

Abstract

Laser photocoagulation is a well-established treatment modality for retinal disease. Discrete laser burns can be placed anywhere in the retina, singly or multiply, and the burn intensity is controllable. This study investigates the effect of prior laser photocoagulation on the retinal transduction properties of intravitreally administered adeno-associated viral (AAV) vectors. C57BL/6J mice were subjected to unilateral laser photocoagulation 48 hr before bilateral intravitreal injection of self-complementary cytomegaloviral enhanced green fluorescent protein (EGFP) vectors packaged in AAV type 2, 5, and 8 capsids. The eyes were enucleated 4 weeks after injection and examined by histochemistry and quantitative image analysis. Laser pretreatment resulted in substantially increased localized transduction around the burn site for all AAV capsid types. Without laser pretreatment, the vectors transduced only ganglion cells (AAV2) or sporadic cells around the optic nerve head (AAV5 and AAV8). Laser pretreatment increased AAV2 vector expression throughout the entire retina and focally at the burn site. Transduced cells at the burn site included retinal pigment epithelium (RPE), photoreceptors, Müller cells, inner nuclear layer cells, and retinal ganglion cells. The AAV5 vector showed increased RPE transduction at the burn site only. The AAV8 vector showed augmented expression in RPE, photoreceptors, and Müller cells around the burn site. Migrating RPE cells, present in the neural retina near the burn site, were also transduced by all three capsid types as evidenced by colocalization of EGFP and cytokeratin. Laser photocoagulation can be used to precisely direct AAV vector transduction to discrete locations in the retina. A combination of laser and AAV-mediated gene expression may allow the development of improved therapies for diabetic retinopathy, branch and central vein occlusion, and age-related macular degeneration.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24191872      PMCID: PMC3904656          DOI: 10.1089/hgtb.2013.089

Source DB:  PubMed          Journal:  Hum Gene Ther Methods        ISSN: 1946-6536            Impact factor:   2.396


  47 in total

1.  Recurrent choroidal neovascularization after argon laser photocoagulation for neovascular maculopathy. Macular Photocoagulation Study Group.

Authors: 
Journal:  Arch Ophthalmol       Date:  1986-04

2.  Patterns of cytokeratin and vimentin expression in the human eye.

Authors:  M Kasper; R Moll; P Stosiek; U Karsten
Journal:  Histochemistry       Date:  1988

3.  Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study.

Authors:  David M Brown; Peter A Campochiaro; Rishi P Singh; Zhengrong Li; Sarah Gray; Namrata Saroj; Amy Chen Rundle; Roman G Rubio; Wendy Yee Murahashi
Journal:  Ophthalmology       Date:  2010-04-09       Impact factor: 12.079

Review 4.  Glial fibrillary acidic protein (GFAP): the major protein of glial intermediate filaments in differentiated astrocytes.

Authors:  L F Eng
Journal:  J Neuroimmunol       Date:  1985-06       Impact factor: 3.478

5.  Intravitreal injection of AAV2 transduces macaque inner retina.

Authors:  Lu Yin; Kenneth Greenberg; Jennifer J Hunter; Deniz Dalkara; Kathleen D Kolstad; Benjamin D Masella; Robert Wolfe; Meike Visel; Daniel Stone; Richard T Libby; David Diloreto; David Schaffer; John Flannery; David R Williams; William H Merigan
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-04-25       Impact factor: 4.799

6.  Distribution of glial fibrillary acidic protein in normal and gliotic human retina.

Authors:  G Tuccari; C Trombetta; M M Giardinelli; F Arena; G Barresi
Journal:  Basic Appl Histochem       Date:  1986

7.  Inner limiting membrane barriers to AAV-mediated retinal transduction from the vitreous.

Authors:  Deniz Dalkara; Kathleen D Kolstad; Natalia Caporale; Meike Visel; Ryan R Klimczak; David V Schaffer; John G Flannery
Journal:  Mol Ther       Date:  2009-08-11       Impact factor: 11.454

8.  Argon laser scatter photocoagulation for prevention of neovascularization and vitreous hemorrhage in branch vein occlusion. A randomized clinical trial. Branch Vein Occlusion Study Group.

Authors: 
Journal:  Arch Ophthalmol       Date:  1986-01

9.  Visual loss following panretinal photocoagulation for proliferative diabetic retinopathy.

Authors:  H R McDonald; H Schatz
Journal:  Ophthalmology       Date:  1985-03       Impact factor: 12.079

Review 10.  Up-regulation of glial fibrillary acidic protein in response to retinal injury: its potential role in glial remodeling and a comparison to vimentin expression.

Authors:  Geoffrey P Lewis; Steven K Fisher
Journal:  Int Rev Cytol       Date:  2003
View more
  12 in total

1.  Laser Photocoagulation Induces Transduction of Retinal Pigment Epithelial Cells by Intravitreally Administered Adeno-Associated Viral Vectors.

Authors:  Si Hyung Lee; Yoon Jin Kong; Jungmook Lyu; Heuiran Lee; Keerang Park; Tae Kwann Park
Journal:  Hum Gene Ther Methods       Date:  2015-10       Impact factor: 2.396

2.  Diabetes enhances the efficacy of AAV2 vectors in the retina: therapeutic effect of AAV2 encoding vasoinhibin and soluble VEGF receptor 1.

Authors:  Nundehui Díaz-Lezama; Zhijian Wu; Elva Adán-Castro; Edith Arnold; Miguel Vázquez-Membrillo; David Arredondo-Zamarripa; Maria G Ledesma-Colunga; Bibiana Moreno-Carranza; Gonzalo Martinez de la Escalera; Peter Colosi; Carmen Clapp
Journal:  Lab Invest       Date:  2015-11-16       Impact factor: 5.662

3.  Expression of Aquaporin-6 in Rat Retinal Ganglion Cells.

Authors:  Sun Young Jang; Eung Suk Lee; Young-Hoon Ohn; Tae Kwann Park
Journal:  Cell Mol Neurobiol       Date:  2015-11-02       Impact factor: 5.046

4.  Atypical Retinal Pigment Epithelial Hyperplasia and Glial Proliferation Masquerading as Progressive Recurrent Retinoblastoma: A Case Report Review and Clinicopathologic Correlation.

Authors:  Emily Zolfaghari; Jonathan W Kim; Subramanian Krishnan; Patricia Chévez-Barrios; Jesse L Berry
Journal:  Ocul Oncol Pathol       Date:  2017-09-16

Review 5.  Retinal Gene Therapy: Surgical Vector Delivery in the Translation to Clinical Trials.

Authors:  G Alex Ochakovski; K Ulrich Bartz-Schmidt; M Dominik Fischer
Journal:  Front Neurosci       Date:  2017-04-03       Impact factor: 4.677

6.  Adeno-Associated Viral Vector-Mediated mTOR Inhibition by Short Hairpin RNA Suppresses Laser-Induced Choroidal Neovascularization.

Authors:  Tae Kwann Park; Si Hyung Lee; Jun Sub Choi; Seung Kwan Nah; Hee Jong Kim; Ha Yan Park; Heuiran Lee; Steven Hyun Seung Lee; Keerang Park
Journal:  Mol Ther Nucleic Acids       Date:  2017-06-01       Impact factor: 8.886

7.  scAAV2-Mediated C3 Transferase Gene Therapy in a Rat Model with Retinal Ischemia/Reperfusion Injuries.

Authors:  Junkai Tan; Xiaoguang Zhang; Danli Li; Guo Liu; Yun Wang; Daren Zhang; Xizhen Wang; Wenhong Tian; Xiaoyan Dong; Liang Zhou; Xianjun Zhu; Xuyang Liu; Ning Fan
Journal:  Mol Ther Methods Clin Dev       Date:  2020-04-25       Impact factor: 6.698

8.  Transduction Pattern of AAVs in the Trabecular Meshwork and Anterior-Segment Structures in a Rat Model of Ocular Hypertension.

Authors:  Si Hyung Lee; Kyeong Sun Sim; Chan Yun Kim; Tae Kwann Park
Journal:  Mol Ther Methods Clin Dev       Date:  2019-07-10       Impact factor: 6.698

9.  Peripapillary Intravitreal Injection Improves AAV-Mediated Retinal Transduction.

Authors:  Sanjar Batirovich Madrakhimov; Jin Young Yang; Dong Hyuck Ahn; Jung Woo Han; Tae Ho Ha; Tae Kwann Park
Journal:  Mol Ther Methods Clin Dev       Date:  2020-03-30       Impact factor: 6.698

10.  Transduction Patterns of Adeno-associated Viral Vectors in a Laser-Induced Choroidal Neovascularization Mouse Model.

Authors:  Si Hyung Lee; Ye Seul Kim; Seung Kwan Nah; Hee Jong Kim; Ha Yan Park; Jin Young Yang; Keerang Park; Tae Kwann Park
Journal:  Mol Ther Methods Clin Dev       Date:  2018-01-31       Impact factor: 6.698

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.